Capricor Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

Go back to Capricor Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

Capricor Therapeutics (CAPR) Misses Q1 EPS by 2c

May 10, 2018 4:03 PM EDT

Capricor Therapeutics (NASDAQ: CAPR) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More